Immuneering Corp (IMRX)
2.11
+0.07
(+3.43%)
USD |
NASDAQ |
Nov 21, 16:00
2.12
+0.01
(+0.47%)
After-Hours: 20:00
Immuneering Net Income (Quarterly): -14.60M for Sept. 30, 2024
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -14.60M |
| June 30, 2024 | -14.08M |
| March 31, 2024 | -14.31M |
| December 31, 2023 | -15.08M |
| September 30, 2023 | -12.60M |
| June 30, 2023 | -12.19M |
| March 31, 2023 | -13.60M |
| December 31, 2022 | -13.25M |
| September 30, 2022 | -12.84M |
| June 30, 2022 | -11.53M |
| Date | Value |
|---|---|
| March 31, 2022 | -12.90M |
| December 31, 2021 | -10.78M |
| September 30, 2021 | -8.534M |
| June 30, 2021 | -7.988M |
| March 31, 2021 | -6.230M |
| December 31, 2020 | -5.836M |
| September 30, 2020 | -4.399M |
| June 30, 2020 | -3.604M |
| March 31, 2020 | -3.201M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-15.08M
Minimum
Dec 2023
-3.201M
Maximum
Mar 2020
-10.40M
Average
-12.19M
Median
Jun 2023
Net Income (Quarterly) Benchmarks
| Singular Genomics Systems Inc | -16.80M |
| Biomarin Pharmaceutical Inc | 106.08M |
| Integra Lifesciences Holdings Corp | -10.70M |
| Eton Pharmaceuticals Inc | 0.627M |
| Tenon Medical Inc | -3.184M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 15.27M |
| EPS Diluted (Quarterly) | -0.49 |
| Enterprise Value | 14.86M |
| Earnings Yield | -93.36% |
| Normalized Earnings Yield | -91.00 |